(Q41342855)

English

Prolactin disorders

scientific article published on February 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 September 2017

1 reference

Europe PubMed Central

Prolactin disorders (English)

1 reference

Europe PubMed Central

29 September 2017

Wael A. Salameh

3

1 reference

Europe PubMed Central

29 September 2017

author name string

Yazigi RA

1

1 reference

Europe PubMed Central

29 September 2017

Quintero CH

2

1 reference

Europe PubMed Central

29 September 2017

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

29 September 2017

Fertility and Sterility

1 reference

Europe PubMed Central

29 September 2017

67

1 reference

Europe PubMed Central

29 September 2017

2

1 reference

Europe PubMed Central

29 September 2017

215-225

1 reference

Europe PubMed Central

29 September 2017

The prolactin gene is located on chromosome 6 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

EXPRESSION OF THE PROLACTIN GENE IN HUMAN DECIDUA-CHORION

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Decidual-type prolactin expression by the human myometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Human pituitary prolactin (hPRL): the entire linear amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin production by human endometrium during the normal menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Variation among species in the endocrine control of mammary growth and function: the roles of prolactin, growth hormone, and placental lactogen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Amniotic Prolactin Control Over Amniotic and Fetal Extracellular Fluid Water and Electrolytes in the Rhesus Monkey12

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin release from perifused human decidual explants; effects of decidual prolactin-releasing factor (PRL-RF) and prolactin release-inhibitory factor (PRL-IF)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Decidual production of prolactin in late gestation: further evidence for a decidual source of amniotic fluid prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin modulation of dehydroepiandrosterone sulfate secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Two forms of glycosylated human prolactin have different pigeon crop sac-stimulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin molecular heterogeneity. Response to thyrotropin-releasing hormone stimulation of concanavalin A-bound and -unbound immunoassayable prolactin during human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

A glycosylated prolactin species is covalently bound to immunoglobulin in human amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Large Molecular Size Prolactin with Reduced Receptor Activity in Human Serum: High Proportion in Basal State and Reduction after Thyrotropin-Releasing Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Evidence that serotonin neurons stimulate secretion of prolactin releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin release by vasoactive intestinal polypeptide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin stimulation by protein is mediated by amino acids in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Relation of sleep-entrained human prolactin release to REM-nonREM cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Pattern of increase in circulating prolactin levels during human gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Multiphasic prolactin secretion during parturition in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Human Prolactin and Growth Hormone Release during Surgery and other Conditions of Stress1

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Adenosine 3′,5′-Monophosphate (cAMP) and Calcium-Calmodulin Interrelation in the Control of Prolactin Secretion: Evidence for Dopamine Inhibition of cAMP Accumulation and Prolactin Release after Calcium Mobilization*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Evidence for an increased opioid inhibition of luteinizing hormone secretion in hyperprolactinemic patients with pituitary microadenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin Inhibition of Luteinizing Hormone-Stimulated Androgen Synthesis in Ovarian Interstitial Cells Cultured in Defined Medium: Mechanism of Action*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin inhibition of estrogen production by cultured rat granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

The natural history of untreated microprolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Serum prolactin levels in untreated primary hypothyroldism

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin secreting renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Ectopic prolactin secretion from a gonadoblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Studies of prolactin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Mammary Stimulation causes Prolactin Secretion in Non-lactating Women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Both type I and II insulin-like growth factor receptor binding increase during lactogenesis in bovine mammary tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Characterization of the change in type I and II insulin-like growth factor receptors of bovine mammary tissue during the pre- and postpartum periods

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Thyrotropin-Releasing Hormone Stimulates Release of Arginine Vasopressin and Oxytocin inVivo*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Specific cytoplasmic glucocorticoid hormone receptors in lactating mammary glands.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Estradiol inhibits prolactin induced alpha-lactalbumin production in normal primate mammary tissue in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

A prospective longitudinal study of the release of oxytocin and prolactin in response to infant suckling in long term lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Primary amenorrhea and pseudoprolactinoma in a patient with primary hypothyroidism. Reversal of clinical, biochemical, and radiologic abnormalities with levothyroxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Galactorrhea: a study of 235 cases, including 48 with pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Bone density in amenorrheic women with and without hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Effects of prolactin and estrogen deficiency in amenorrheic bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Reduction of serum-prolactin after subcutaneous salmon calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Stimulation of Intestinal Calcium Transport and Bone Calcium Mobilization by Prolactin in Vitamin D-Deficient Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

MR imaging of pituitary adenoma: CT, clinical, and surgical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Analysis of clinical backgrounds and pathogenesis of luteal-phase defect

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

The effects on the ovulatory cycle of metoclopramide-induced increased prolactin levels during follicular development

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Drugs five years later. Bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Does metergoline selectively attenuate 5-HT mediated prolactin release?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Increased circulating levels of bromocriptine after vaginal compared with oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Management of patients with hyperprolactinemia and normal or abnormal tomograms

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Influence of previous bromocriptine therapy on surgery for microprolactinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Pathologic hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Hypopituitarism following radiation therapy of pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

Relationship Between Plasma Prolactin and the Endocrine Microenvironment of the Developing Human Antral Follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperprolactinemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2981900-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(97)81900-0

1 reference

Europe PubMed Central

29 September 2017

1 reference

Europe PubMed Central

29 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41342855&oldid=2095952900"